<DOC>
	<DOC>NCT00150397</DOC>
	<brief_summary>This is an initial proof of concept, phase to study to assess the safety and efficacy tofimilast for the chronic maintenance treatment of adults with persistent asthma</brief_summary>
	<brief_title>A Study of the Safety and Efficacy of Tofimilast in Adult Asthmatics</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Mild to moderate persistent asthma (NAEPP/GINA Step 23) Reversibility to albuterol at least 12% and 200 mL Any significant comorbid disease, particularly cardiovascular Use of any maintenance therapy except short acting bronchodilators Smoking history &gt; or = 10 years</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>